Efficacy of 2 weeks' application of theophylline ointment in psoriasis vulgaris

Journal of Dermatological Treatment

Volumn 16, Issue 3, 2005, Pages 169-170

  Papakostantinou, E ^a   Xenos, K ^a   Markantonis, Sophia L ^a   Druska, S ^a   Stratigos, A ^a   Katsambas, A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

PASI score; Psoriasis vulgaris; Theophylline ointment

Indexed keywords

DIETHYLENE GLYCOL MONOETHYL ETHER; OLEIC ACID; PLACEBO; THEOPHYLLINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HUMAN; MALE; OINTMENT; PRIORITY JOURNAL; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; OINTMENTS; PSORIASIS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; THEOPHYLLINE; TREATMENT OUTCOME;

EID: 25444531206     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630510043202     Document Type: Article

References (11)

1. Iancu L. Experimental treatment of psoriasis with compounds which increase the intracellular level of cAMP. MSc thesis, Tel Aviv University, 1979.
2. Iancu L, Shneur A, Cohen H. Trials with xanthine derivatives in systemic treatment of psoriasis. Dermatologica. 1979;159:55-61.
3. Golchai J, Kishavars D. Treatment of psoriasis with topical aminophylline. Int J Dermatol. 1994;33:885.
4. Levi-Schaffer F, Touitou E. Xanthines inhibit 3T3 fibroblast proliferation. Skin Pharmacol. 1991;4:286-90.
5. Levi-Schaffer F, Dayan N, Touitou E. Diethylene glycol monoethyl ether (Transcutol) displays antiproliferative properties alone and in combination with xanthines. Skin Pharmacol. 1996;9:53-9.
6. Touitou E, Levi-Schaffer F, Shaco-Ezra N, Ben-Yossef R, Fabin B. Enhanced permeation of theophylline through the skin and its effect on fibroblast proliferation. Int J Pharmacol. 1991;70:159-66.
7. Touitou E, Levi-Schaffer F, Dayan N, Alhaique F, Riccieri F. Modulation of caffeine skin delivery by carrier design: liposomes versus permeation enhancers. Int J Pharmacol. 1994;103:131-6.
8. Data sheet. St Priest, France: Gattefosse.
9. Van de Kerkhof PCM. On the limitations of the psoriasis area and severity index (PASI). Br J Dermatol. 1992;126:205.
10. Shukla AJ, Mahashabde S. Novel uses of gelucres and transcutol in drug formulation. St Priest, France: Gattefosse, 55-60.
11. Ritschel WA, Hussain AS. In vitro skin penetration of griseofulvin in rat and human skin from ointment dosage form. Arzneimittelforschung/Drug Res. 1988;38:1630-32.